SCHEMBL6981311

SCHEMBL6981311

CCNc1nc(NCC)nc(-c2ccc(-c3ccccc3)cc2)n1

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
IDH1 O75874 1/20 0.54
ADORA1 P30542 4/20 0.53
ADORA2A P29274 3/20 0.53
NPSR1 Q6W5P4 1/20 0.50
CYP1A2 P05177 3/20 0.48
CYP1A1 P04798 2/20 0.48
L3MBTL1 Q9Y468 2/20 0.47
NPC1 O15118 1/20 0.47
CYP2C19 P33261 1/20 0.47
RAB9A P51151 1/20 0.47
IDH2 P48735 1/20 0.45
PKM P14618 1/20 0.44
MAPK1 P28482 1/20 0.44
PDE5A O76074 1/20 0.44
POLB P06746 1/20 0.44
LMNA P02545 1/20 0.44
ADORA2B P29275 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8052100 0.96 IDH1 (0.57) IDH1ADORA1ADORA2ANPSR1CYP1A2
SCHEMBL23839453 0.84 ADORA1 (0.49) IDH1ADORA1ADORA2ANPSR1CYP1A2
SCHEMBL6269189 0.84 NPSR1 (0.71) IDH1ADORA1ADORA2ANPSR1NPC1
SCHEMBL13140035 0.81 IDH1 (0.63) IDH1NPSR1CYP1A2L3MBTL1NPC1
SCHEMBL15102377 0.81 KCNH3 (0.56) IDH1ADORA1ADORA2AIDH2POLB
SCHEMBL29763360 0.81 KCNH3 (0.56) IDH1ADORA1ADORA2AIDH2POLB
SCHEMBL18510329 0.80 IDH2 (0.52) CYP1A2L3MBTL1NPC1CYP2C19RAB9A
SCHEMBL24303801 0.79 LMNA (0.50) ADORA1ADORA2ANPSR1CYP1A2CYP1A1
SCHEMBL7537505 0.79 POLB (0.65) IDH1NPSR1NPC1RAB9AMAPK1
SCHEMBL6978463 0.79 TDP1 (0.57) IDH1ADORA1ADORA2ACYP1A2CYP1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1037886-B1 TRIAZINE ANGIOGENESIS INHIBITORS ABBOTT LAB (US) 2003-05-02 EP claimed
US-6150362-A ADMINISTERING 1,3,5-SUBSTITUTED TRIAZINE COMPOUNDS TO THE PATIENT SUFFERING FROM ANGIOGENIC DISEASES ABBVIE INC. 2000-11-21 US claimed
EP-1037886-B1 TRIAZINE ANGIOGENESIS INHIBITORS ABBOTT LAB (US) 2003-05-02 EP disclosed
US-6288228-B1 DIAMINOTRIAZINE DERIVATIVES ABBOTT LABORATORIES 2001-09-11 US disclosed
US-6150362-A ADMINISTERING 1,3,5-SUBSTITUTED TRIAZINE COMPOUNDS TO THE PATIENT SUFFERING FROM ANGIOGENIC DISEASES ABBVIE INC. 2000-11-21 US disclosed